Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice
Science Advances · 2023
DOI: 10.1126/sciadv.ade0059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Wen Bu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Gene Editing, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCRR NIH HHS, NIH HHS.
Abstract (Originalsprache)
CRISPR-Cas9 has been used successfully to introduce indels in somatic cells of rodents; however, precise editing of single nucleotides has been hampered by limitations of flexibility and efficiency. Here, we report technological modifications to the CRISPR-Cas9 vector system that now allows homology-directed repair–mediated precise editing of any proto-oncogene in murine somatic tissues to generate tumor models with high flexibility and efficiency. Somatic editing of either Kras or Pik3ca in both normal and hyperplastic mammary glands led to swift tumorigenesis. The resulting tumors shared some histological, transcriptome, and proteome features with tumors induced by lentivirus-mediated expression of the respective oncogenes, but they also exhibited some distinct characteristics, particularly showing less intertumor variation, thus potentially offering more consistent models for cancer studies and therapeutic development. Therefore, this technological advance fills a critical gap between the power of CRISPR technology and high-fidelity mouse models for studying human tumor evolution and preclinical drug testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
- Department of Education, Innovation, and Technology, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Wen Bu, Chad J Creighton, Kelsey S Heavener, Carolina Gutierrez, Yongchao Dou, Yiqun Zhang, Jazmin Urrutia, Wen Jiang, Luyu Jia, Ahmed Atef Ibrahim, Bing Zhang, Shixia Huang, Yi Li
Förderung
- NCI NIH HHS
- NCRR NIH HHS
- NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Bu, W., Creighton, C. J., Heavener, K. S., Gutierrez, C., Dou, Y., Ku, A. T., Zhang, Y., Jiang, W., Urrutia, J., Jiang, W., Yue, F., Jia, L., Ibrahim, A. A., Zhang, B., Huang, S., & Li, Y. (2023). Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice. Science Advances. https://doi.org/10.1126/sciadv.ade0059
Vancouver
Bu W, Creighton CJ, Heavener KS, Gutierrez C, Dou Y, Ku AT, et al. Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice. Science Advances. 2023. doi:10.1126/sciadv.ade0059
BibTeX
@article{Bu2023,
author = {Bu, Wen and Creighton, Chad J and Heavener, Kelsey S and Gutierrez, Carolina and Dou, Yongchao and Ku, Amy T and Zhang, Yiqun and Jiang, Weiyu and Urrutia, Jazmin and Jiang, Wen and Yue, Fei and Jia, Luyu and Ibrahim, Ahmed Atef and Zhang, Bing and Huang, Shixia and Li, Yi},
title = {Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade0059}
}
EUVIMED